Global Allergy Treatment Market to Reach US$24.1 Billion by 2030

The global market for Allergy Treatment estimated at US$19.4 Billion in the year 2024, is expected to reach US$24.1 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Asthma, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Rhinitis segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.2 Billion While China is Forecast to Grow at 6.4% CAGR

The Allergy Treatment market in the U.S. is estimated at US$5.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Allergy Treatment - Key Trends and Drivers

Allergy treatment has become increasingly essential in modern healthcare, addressing the rising prevalence of allergic conditions worldwide. Allergies, which are hypersensitive immune responses to substances such as pollen, food, or pet dander, affect millions of individuals, causing symptoms ranging from mild discomfort to severe anaphylaxis. The primary types of allergies include respiratory allergies (such as hay fever and asthma), food allergies, skin allergies (such as eczema), and insect sting allergies. Treatment options vary depending on the type and severity of the allergy and include medications, immunotherapy, and lifestyle modifications. Antihistamines, corticosteroids, decongestants, and leukotriene inhibitors are commonly used to manage symptoms, while immunotherapy, including subcutaneous injections and sublingual tablets, offers long-term relief by desensitizing the immune system to specific allergens. The effectiveness of these treatments has made managing allergies more attainable, improving the quality of life for many patients.

A significant trend in allergy treatment is the development of targeted biologic therapies, which offer a more personalized approach to managing severe allergic conditions. Biologics, such as monoclonal antibodies, work by specifically targeting components of the immune system involved in allergic reactions. For instance, omalizumab, a monoclonal antibody used in the treatment of severe asthma and chronic urticaria, targets immunoglobulin E (IgE), a key player in allergic responses. These advanced treatments are particularly beneficial for patients who do not respond adequately to traditional therapies. Additionally, there is a growing emphasis on non-pharmacological interventions, including allergen avoidance strategies and the use of air purifiers and hypoallergenic products, to minimize exposure to allergens. Advances in diagnostic techniques, such as component-resolved diagnostics, enable more precise identification of allergen sensitivities, allowing for tailored treatment plans. The integration of telemedicine in allergy care has also improved access to specialist consultations and ongoing management, particularly in remote or underserved areas.

The growth in the allergy treatment market is driven by several factors, including the increasing prevalence of allergic conditions, advancements in biologic therapies, and the rise in awareness about allergy management. The rising incidence of allergies, influenced by factors such as environmental pollution, lifestyle changes, and genetic predisposition, has led to greater demand for effective treatments. Technological advancements in drug development have facilitated the introduction of innovative biologic therapies that provide targeted relief for severe allergies, expanding treatment options. Growing awareness about the importance of early diagnosis and proactive management of allergies has prompted more individuals to seek medical advice and adhere to treatment regimens. Furthermore, the expansion of healthcare infrastructure and the availability of over-the-counter allergy medications have made allergy treatments more accessible. The increasing adoption of telemedicine and digital health solutions is also contributing to market growth by enhancing patient access to care and improving treatment adherence. These factors collectively drive the robust growth of the allergy treatment market, ensuring better management of allergic conditions and improved patient outcomes.